SCHEMBL4398938

SCHEMBL4398938

N=C(NO)c1ccnc(N2CCCCC2)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 2/20 0.46
PIK3CA P42336 2/20 0.44
PROKR1 Q8TCW9 4/20 0.43
PRKD3 O94806 1/20 0.42
PRKD1 Q15139 1/20 0.42
PRKD2 Q9BZL6 1/20 0.42
UBE2T Q9NPD8 1/20 0.41
CTSA P10619 1/20 0.41
HDAC3 O15379 2/20 0.40
HDAC1 Q13547 2/20 0.40
PRMT5 O14744 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
DYRK1A Q13627 2/20 0.39
WNT1 P04628 1/20 0.39
GSK3B P49841 1/20 0.39
ALDH1A1 P00352 1/20 0.38
RAB9A P51151 1/20 0.38
CXCR4 P61073 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4397754 0.85 PIK3CA (0.43) PIK3CAPROKR1CTSAPRMT5ALDH1A1
SCHEMBL4411361 0.85 PIK3CA (0.63) PIK3CAPRMT5DYRK1AWNT1GSK3B
SCHEMBL30505327 0.76 PIK3CA (0.72) HRH4PIK3CAPROKR1PRKD3PRKD1
SCHEMBL1255519 0.76 PIK3CA (0.72) HRH4PIK3CAPROKR1PRKD3PRKD1
SCHEMBL27991055 0.76 PIK3CA (0.58) HRH4PIK3CAPROKR1PRKD3PRKD1
SCHEMBL15891156 0.75 UBE2T (0.67) UBE2TSMN1; SMN2ALDH1A1RAB9A
SCHEMBL12640115 0.75 PIK3CA (0.54) HRH4PIK3CAPROKR1PRKD3PRKD1
SCHEMBL30290310 0.75 PRKD3 (0.62) HRH4PIK3CAPROKR1PRKD3PRKD1
SCHEMBL3750019 0.75 HRH3 (0.57) HRH4PIK3CAPROKR1PRKD3PRKD1
SCHEMBL31143236 0.74 PIK3CA (0.74) PIK3CAPROKR1PRKD3PRKD1PRKD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1959951-B1 HETEROARYL SUBSTITUTED PIPERIDINE DERIVATIVES AS L-CPT1 INHIBITORS HOFFMANN LA ROCHE (CH) 2009-12-23 EP disclosed